E09.33
Drug or chemical induced diabetes mellitus with moderate nonproliferative diabetic retinopathy
Clinical Classification Guidelines
7th Character Definition
One of the following 7th characters is to be assigned to codes in subcategory E09.33 to designate laterality of the disease:
Medical Intelligence & Overview
ICD-10 code E09.33 refers to a form of diabetes mellitus caused by the use of certain drugs or chemicals. This condition is characterized by moderately ongoing damage to the small blood vessels in the retina, known as nonproliferative diabetic retinopathy. While diabetes itself affects how the body manages blood sugar, this specific type is triggered by external substances, and it presents with particular eye-related complications.
Causes & Symptoms
Clinical Causes: Use of medications such as corticosteroids, antipsychotics, or certain diuretics Exposure to toxic chemicals or substances that impair insulin function Long-term use or high doses of chemicals that interfere with glucose regulation
Key Symptoms: Blurred or fluctuating vision Presence of floaters or spots in the visual field Darkened or reddened areas in the visual field Signs of eye discomfort, such as dryness or irritation Increased thirst, frequent urination, or unexplained weight loss (related to diabetes)
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a comprehensive medical review of medication and chemical exposure history, combined with blood tests to measure blood sugar levels. An eye examination is essential to detect the characteristic signs of nonproliferative diabetic retinopathy, including microaneurysms, hemorrhages, and retinal swelling. Additional imaging tests like fundus photography or optical coherence tomography (OCT) may be used for detailed assessment.
Treatment Protocols: Managing this condition requires a two-pronged approach: addressing the underlying cause and controlling blood sugar levels. Discontinuing or adjusting the use of the offending drug or chemical is often necessary. Blood sugar management may include lifestyle modifications, medication, or insulin therapy. Regular eye examinations are crucial to monitor retinopathy progression and to implement treatments that can prevent further vision loss, such as laser therapy or intravitreal injections.
Clinical Advice & FAQs
Billing Guidance
Is E09.33 a billable ICD-10 code?
Yes, E09.33 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report E09.33?
Clinical documentation must specify the nature of Drug or chemical induced diabetes mellitus with moderate nonproliferative diabetic retinopathy and any associated comorbidities for accurate reporting.
Cite this Clinical Reference